132 related articles for article (PubMed ID: 9657629)
41. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
42. Cardiac weight in hypertension induced by nitric oxide synthase blockade.
Arnal JF; el Amrani AI; Chatellier G; Ménard J; Michel JB
Hypertension; 1993 Sep; 22(3):380-7. PubMed ID: 8349331
[TBL] [Abstract][Full Text] [Related]
43. Red wine polyphenols prevent cardiovascular alterations in L-NAME-induced hypertension.
Pechánová O; Bernátová I; Babál P; Martínez MC; Kyselá S; Stvrtina S; Andriantsitohaina R
J Hypertens; 2004 Aug; 22(8):1551-9. PubMed ID: 15257179
[TBL] [Abstract][Full Text] [Related]
44. Nipradilol prevents L-NAME-exacerbated nephrosclerosis with decreasing of caspase-3 expression in SHR.
Inada H; Ono H; Minami J; Ishimitsu T; Matsuoka H
Hypertens Res; 2002 May; 25(3):433-40. PubMed ID: 12135323
[TBL] [Abstract][Full Text] [Related]
45. Important role of nitric oxide in the effect of angiotensin-converting enzyme inhibitor imidapril on vascular injury.
Chen R; Iwai M; Wu L; Suzuki J; Min LJ; Shiuchi T; Sugaya T; Liu HW; Cui TX; Horiuchi M
Hypertension; 2003 Oct; 42(4):542-7. PubMed ID: 12963679
[TBL] [Abstract][Full Text] [Related]
46. Role of the central nervous system in the development of hypertension produced by chronic nitric oxide blockade in rats.
Nakata T; Takeda K; Harada S; Oguni A; Hatta T; Kawa T; Itoh H; Sasaki S; Nakagawa M
Hypertens Res; 2001 Jan; 24(1):39-45. PubMed ID: 11213029
[TBL] [Abstract][Full Text] [Related]
47. Long-term inhibition of nitric oxide synthesis increases arterial thrombogenecity in rat carotid artery.
Kubo-Inoue M; Egashira K; Usui M; Takemoto M; Ohtani K; Katoh M; Shimokawa H; Takeshita A
Am J Physiol Heart Circ Physiol; 2002 Apr; 282(4):H1478-84. PubMed ID: 11893585
[TBL] [Abstract][Full Text] [Related]
48. Combination therapy with telmisartan and spironolactone alleviates L-NAME exacerbated nephrosclerosis with an increase in PPAR-gamma and decrease in TGF-beta(1).
Takahashi T; Ono H; Ono Y; Ishimitsu T; Matsuoka H
Int Heart J; 2007 Sep; 48(5):637-47. PubMed ID: 17998773
[TBL] [Abstract][Full Text] [Related]
49. Effects of imidapril on NOS expression and myocardial remodelling in failing heart of Dahl salt-sensitive hypertensive rats.
Kobayashi N; Higashi T; Hara K; Shirataki H; Matsuoka H
Cardiovasc Res; 1999 Dec; 44(3):518-26. PubMed ID: 10690283
[TBL] [Abstract][Full Text] [Related]
50. Role of endothelin ET(A) receptors in the hypertension produced by 4-day L-nitroarginine methyl ester and cyclosporine treatment.
Pollock DM; Polakowski JS; Opgenorth TJ; Pollock JS
Eur J Pharmacol; 1998 Apr; 346(1):43-50. PubMed ID: 9617750
[TBL] [Abstract][Full Text] [Related]
51. Calcium antagonist inhibits glomerular cell apoptosis and injuries of L-NAME exacerbated nephrosclerosis in SHR.
Watanabe S; Ono H; Ishimitsu T; Matsuoka H; Ono Y; Fujimori T
Hypertens Res; 2000 Nov; 23(6):683-91. PubMed ID: 11131282
[TBL] [Abstract][Full Text] [Related]
52. Chronic and acute effects of different antihypertensive drugs on femoral artery relaxation of L-NAME hypertensive rats.
Sládková M; Kojsová S; Jendeková L; Pechánová O
Physiol Res; 2007; 56 Suppl 2():S85-S91. PubMed ID: 17824802
[TBL] [Abstract][Full Text] [Related]
53. Effects of lipopolysaccharide on the blood-brain barrier permeability in prolonged nitric oxide blockade-induced hypertensive rats.
Ahishali B; Kaya M; Kalayci R; Uzun H; Bilgic B; Arican N; Elmas I; Aydin S; Kucuk M
Int J Neurosci; 2005 Feb; 115(2):151-68. PubMed ID: 15763998
[TBL] [Abstract][Full Text] [Related]
54. Effects of captopril on cardiac and renal damage, and metabolic alterations in the nitric oxide-deficient hypertensive rat.
Khattab MM; Mostafa A; Al-Shabanah O
Kidney Blood Press Res; 2005; 28(4):243-50. PubMed ID: 16220007
[TBL] [Abstract][Full Text] [Related]
55. [Contribution of the renin-angiotensin system to the variability of blood pressure in hypertensive rat after blockade of nitric oxide synthesis].
Gouédard O; Gaudet E; Blanc J; Ponchon P; Elghozi JL
Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1013-7. PubMed ID: 8949370
[TBL] [Abstract][Full Text] [Related]
56. Angiotensin II subtype AT1 receptor blockade prevents hypertension and renal insufficiency induced by chronic NO-synthase inhibition in rats.
Hropot M; Langer KH; Wiemer G; Grötsch H; Linz W
Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar; 367(3):312-7. PubMed ID: 12644905
[TBL] [Abstract][Full Text] [Related]
57. Spironolactone differently influences remodeling of the left ventricle and aorta in L-NAME-induced hypertension.
Simko F; Matúsková J; Lupták I; Pincíková T; Krajcírovicová K; Stvrtina S; Pomsár J; Pelouch V; Paulis L; Pechánová O
Physiol Res; 2007; 56 Suppl 2():S25-S32. PubMed ID: 17824810
[TBL] [Abstract][Full Text] [Related]
58. Effects of imidapril on left ventricular mass in chronic hemodialysis patients.
Matsumoto N; Ishimitsu T; Okamura A; Seta H; Takahashi M; Matsuoka H
Hypertens Res; 2006 Apr; 29(4):253-60. PubMed ID: 16778332
[TBL] [Abstract][Full Text] [Related]
59. Effects of chronic increased salt intake on nitric oxide synthesis inhibition-induced hypertension.
Fernández-Rivas A; García-Estañ J; Vargas F
J Hypertens; 1995 Jan; 13(1):123-8. PubMed ID: 7759842
[TBL] [Abstract][Full Text] [Related]
60. The effect of enalapril and verapamil on the left ventricular hypertrophy and the left ventricular cardiomyocyte numerical density in rats submitted to nitric oxide inhibition.
Pereira LM; Mandarim-De-Lacerda CA
Int J Exp Pathol; 2001 Apr; 82(2):115-22. PubMed ID: 11454102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
